These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 4065698)

  • 1. Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis.
    Robb TA; Davidson GP; Kirubakaran C
    Gut; 1985 Nov; 26(11):1246-56. PubMed ID: 4065698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal bile salts in cystic fibrosis: studies in the patient and experimental animal.
    Harries JT; Muller DP; McCollum JP; Lipson A; Roma E; Norman AP
    Arch Dis Child; 1979 Jan; 54(1):19-24. PubMed ID: 420518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile salt secretion in cirrhosis of the liver.
    Turnberg LA; Grahame G
    Gut; 1970 Feb; 11(2):126-33. PubMed ID: 5441881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid secretion in cystic fibrosis: evidence for a defect unrelated to fat malabsorption.
    Weizman Z; Durie PR; Kopelman HR; Vesely SM; Forstner GG
    Gut; 1986 Sep; 27(9):1043-8. PubMed ID: 3758817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excessive fecal taurine loss predisposes to taurine deficiency in cystic fibrosis.
    Thompson GN
    J Pediatr Gastroenterol Nutr; 1988; 7(2):214-9. PubMed ID: 3351706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic, hepatic, and duodenal mucosal bicarbonate secretion during infusion of secretin and cholecystokinin. Evidence of the importance of hepatic bicarbonate in the neutralization of acid in the duodenum of anaesthetized pigs.
    Ainsworth MA; Ladegaard L; Svendsen P; Cantor P; Olsen O; Schaffalitzky de Muckadell OB
    Scand J Gastroenterol; 1991 Oct; 26(10):1035-41. PubMed ID: 1947769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of pancreas and gallbladder function in children. II. Results in patients with celiac disease, cystic fibrosis of the pancreas and exocrine pancreas insufficiency (author's transl)].
    Niessen KH; Osswald P; Brügmann G; Hartmann F; Droste E; Schmidt K
    Z Kinderheilkd; 1974; 116(4):291-304. PubMed ID: 4825920
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum bile acids and ursodeoxycholic acid treatment in cystic fibrosis-related liver disease.
    O'Brien SM; Campbell GR; Burke AF; Maguire OC; Rowlands BJ; FitzGerald MX; Hegarty JE
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):477-83. PubMed ID: 8804877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The electrolyte and protein contents and outputs in duodenal juice after pancreozymin and secretin stimulation in normal children and in patients with cystic fibrosis.
    Zoppi G; Shmerling DH; Gaburro D; Prader A
    Acta Paediatr Scand; 1970 Nov; 59(6):692-6. PubMed ID: 5478225
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormal pancreatic electrolyte secretion in cystic fibrosis. Reliability as a diagnostic marker.
    Davidson GP; Kirubakaran CP; Ratcliffe G; Cooper DM; Robb TA
    Acta Paediatr Scand; 1986 Jan; 75(1):145-50. PubMed ID: 3953270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cholecystokinin-Pancreozymin on bile salt secretion into the duodenal juice in patients with liver cirrhosis.
    Bode C; Goebell H; Kehl W
    Klin Wochenschr; 1971 Aug; 49(15):881-3. PubMed ID: 5567610
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bile acids in duodenal juice of infants and children. Normal values, lognormal distribution, and age-dependence of the total quantity and the distribution of bile acids (author's transl)].
    Niessen KH
    Monatsschr Kinderheilkd (1902); 1979 Jan; 127(1):29-36. PubMed ID: 759839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duodenal output of lactoferrin in normal subjects and correlation to output of amylase, bicarbonate, and total bile acids.
    Hegnhøj J; Schaffalitzky de Muckadell OB; Lauritzen JB; Magid E
    Scand J Gastroenterol; 1986 Aug; 21(6):705-10. PubMed ID: 3489278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive study of the biliary bile acid composition of patients with cystic fibrosis and associated liver disease before and after UDCA administration.
    Nakagawa M; Colombo C; Setchell KD
    Hepatology; 1990 Aug; 12(2):322-34. PubMed ID: 2391071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal bile acid malabsorption in cystic fibrosis.
    O'Brien S; Mulcahy H; Fenlon H; O'Broin A; Casey M; Burke A; FitzGerald MX; Hegarty JE
    Gut; 1993 Aug; 34(8):1137-41. PubMed ID: 8174969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secretin-pancreozymin test with volume correction in the functional diagnosis of pancreatobiliary secretion].
    Rogos R; Appelt G; Möller T; Wegner D
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(5):242-51. PubMed ID: 3436286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterokinase in human duodenal juice following secretin and pancreozymin and its relationship to bile salts and trypsin.
    Moss S; Lobley RW; Holmes R
    Gut; 1972 Oct; 13(10):851. PubMed ID: 5087109
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of taurine deficiency in cystic fibrosis.
    Thompson GN
    Clin Chim Acta; 1988 Feb; 171(2-3):233-7. PubMed ID: 3370822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the marker technique for measurement of exocrine pancreatic secretion rate.
    Rune SJ; Worning H
    Scand J Gastroenterol; 1985 May; 20(4):525-9. PubMed ID: 4023620
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.